
INDIVIDUAL PHENOTYPE TRAIT VARIABILITY
AS GENETIC MARKERS OF GENDER SUSCEPTIBILITY
TO SPINA BIFIDA Nikolic DP1,*, Cvjeticanin S2,3, Petronic I1,2, Brdar R2,4,
Cirovic D1,2, Bizic M4, Milincic Z1,2, Karan R5 *Corresponding Author: Dejan P. Nikolic, Physical Medicine and Rehabilitation, University Children’s Hospital,
Nikole Stefanovica 3, 11000 Belgrade, Serbia; Tel.: +38-1-638-133-345; Email: denikol27@yahoo.com page: 11
|
INTRODUCTION
Spina bifida (SB) is the incomplete closure of the
neural tube during fetal development [1]. The prevalence
of SB is related to geographic location (higher
in northern Russians than in Norwegians), time of the
conception, gender (higher in females than in males),
mother’s age, folic acid consumption and other factors
[2-6]. It is a multifactorial disease involving genetic
and environmental factors [6]. In support of a genetic
component of SB are reported the gender differences
in prevalence at birth and the higher incidence in
monozygous twins and in relatives of affected patients
[7]. Genes with a suggested linkage to neural
tube defects and SB include those located at 17q11.2-
q12, 1p13, 6q27, 14q24, 1p36.3, 5p15.3-p15.2, 1q43
(OMIM numbers 601634, 182940) and on the X chromosome
(OMIM number 301410) [8-10]. Changes in
the skin, particularly in spina bifida occulta (SBO),
such as hyperpigmentation, hypertrichosis and dermal
sinuses [11], have led Cvjeticanin et al. [12] to investigate
the frequency of recessive homozygosity and
genetic variability in patients with SB. A higher frequency
of recessive homozygosity and decreased genetic variability was reported in patients with SB than
in healthy matched subjects [12]. Increased recessive
homozygosity in several conditions including diabetes
mellitus, congenital hip dislocation, bronchogenic
carcinoma and chronic lymphocytic leukemia, have
also been reported [13,14]. Genetic inheritance [6],
increased incidence of certain skin markers as phenotype
traits [8] and gender differences in prevalence at
birth [7], have led us to investigate the individual phenotype
trait variability in male and in female patients
with SBO and/or spina bifida aperta (SBA) and their
value for the prediction of this disease.
|
|
|
|



 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|